BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34689164)

  • 1. Kinectin1 depletion promotes EGFR degradation via the ubiquitin-proteosome system in cutaneous squamous cell carcinoma.
    Ma J; Ma S; Zhang Y; Shen Y; Huang L; Lu T; Wang L; Wen Y; Ding Z
    Cell Death Dis; 2021 Oct; 12(11):995. PubMed ID: 34689164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma.
    Zhang Y; Gao L; Ma S; Ma J; Wang Y; Li S; Hu X; Han S; Zhou M; Zhou L; Ding Z
    Cell Death Differ; 2019 Oct; 26(10):2061-2073. PubMed ID: 30683916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
    Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y
    J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma.
    Egashira S; Jinnin M; Ajino M; Shimozono N; Okamoto S; Tasaki Y; Hirano A; Ide M; Kajihara I; Aoi J; Harada M; Igata T; Masuguchi S; Fukushima S; Ihn H
    Sci Rep; 2017 Oct; 7(1):12654. PubMed ID: 28978917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.
    Mei XL; Zhong S
    Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.
    Galer CE; Corey CL; Wang Z; Younes MN; Gomez-Rivera F; Jasser SA; Ludwig DL; El-Naggar AK; Weber RS; Myers JN
    Head Neck; 2011 Feb; 33(2):189-98. PubMed ID: 20848439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1.
    Yao T; Song L; Xu W; DeMartino GN; Florens L; Swanson SK; Washburn MP; Conaway RC; Conaway JW; Cohen RE
    Nat Cell Biol; 2006 Sep; 8(9):994-1002. PubMed ID: 16906146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome Subunit Alpha Type-7 Expression Suppresses Cutaneous Squamous Cell Carcinoma Progression by Inhibiting Cancer-associated Cytokines.
    Xu X; Pei M; Kim KY; Xi H; Lee SG; Chung KY; Roh MR; Jin Z
    In Vivo; 2023; 37(4):1584-1592. PubMed ID: 37369480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.
    Qiu XB; Ouyang SY; Li CJ; Miao S; Wang L; Goldberg AL
    EMBO J; 2006 Dec; 25(24):5742-53. PubMed ID: 17139257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
    Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
    Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.
    Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M
    J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.
    Alwan HA; van Zoelen EJ; van Leeuwen JE
    J Biol Chem; 2003 Sep; 278(37):35781-90. PubMed ID: 12829707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
    Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
    J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WW domain-containing E3 ubiquitin protein ligase 1 depletion evokes antitumor effect in cutaneous squamous cell carcinoma by inhibiting signal transducer and activator of transcription 3 signaling pathway.
    Xia Y; Chang X; Lian S; Zhu W
    J Int Med Res; 2018 Jul; 46(7):2898-2912. PubMed ID: 29888632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
    Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
    Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
    Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
    Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
    Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.